About Us
BD2 is bringing together researchers, clinicians, philanthropists, and people with lived experience to approach the study and treatment of bipolar disorder in a new way.
For individuals living with bipolar disorder, their families, and the researchers and clinicians who care for them, BD2 is the transformational force unlocking scientific understanding that will improve clinical outcomes and allow those with bipolar disorder to thrive.
For the past several years, the founding philanthropic partners of BD2 have been working with the Milken Center for Strategic Philanthropy to explore ways to advance scientific understanding and unite the field of bipolar disorder, a space historically underfunded and lacking coordination.
Taking learnings from the development of Aligning Science Across Parkinson’s (ASAP), and working alongside scientists, clinicians, and people with lived experience, the Baszucki, Brin, and Dauten families united with the Milken Institute to establish BD2: Breakthrough Discoveries for thriving with Bipolar Disorder.
Through an integrated, collaborative approach, BD2 will address knowledge gaps in the basic disease mechanisms of bipolar disorder as well as factors influencing clinical approaches and outcomes. This initial $150 million effort provides an unprecedented opportunity to improve the lives of people with bipolar disorder and those yet to be diagnosed.
